Renaissance Technologies (RenTech)'s DARE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 19,295 shares of Daré Bioscience, Inc. (DARE) worth $37,239, representing 0.00% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in DARE, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2020, adding 37,589 shares. Largest reduction occurred in Q2 2021, reducing 66,652 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Daré Bioscience (DARE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Daré Bioscience (DARE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -39,600 | Reduce 67.24% | 19,295 | $1.93 |
| Q3 2025 | -12,900 | Reduce 17.97% | 58,895 | $2.10 |
| Q2 2025 | +1,200 | Add 1.70% | 71,795 | $2.39 |
| Q1 2025 | +1,900 | Add 2.77% | 70,595 | $2.89 |
| Q4 2024 | +4,300 | Add 6.68% | 68,695 | $3.12 |
| Q3 2024 | -497 | Reduce 0.77% | 64,395 | $3.24 |
| Q2 2024 | +1,317 | Add 2.07% | 64,892 | $4.03 |
| Q1 2024 | +3,625 | Add 6.05% | 63,575 | $5.88 |
| Q4 2023 | +4,050 | Add 7.25% | 59,950 | $3.70 |
| Q3 2023 | -4,002 | Reduce 6.68% | 55,900 | $5.55 |
| Q2 2023 | +12,480 | Add 26.32% | 59,902 | $0.01 |
| Q1 2023 | +5,698 | Add 13.66% | 47,422 | $0.01 |
| Q4 2022 | -12,443 | Reduce 22.97% | 41,724 | $0.01 |
| Q3 2022 | +23,617 | Add 77.31% | 54,167 | $12.00 |
| Q2 2022 | +22,188 | Add 265.34% | 30,550 | $14.76 |
| Q1 2022 | +8,362 | New Buy | 8,362 | $17.94 |
| Q4 2021 | -27,002 | Sold Out | 0 | $0.00 |
| Q3 2021 | +20,953 | Add 346.39% | 27,002 | $20.04 |
| Q2 2021 | -66,652 | Reduce 91.68% | 6,049 | $22.65 |
| Q1 2021 | +13,726 | Add 23.27% | 72,701 | $20.27 |
| Q4 2020 | +342 | Add 0.58% | 58,975 | $16.07 |
| Q3 2020 | +4,293 | Add 7.90% | 58,633 | $11.99 |
| Q2 2020 | +37,589 | Add 224.40% | 54,340 | $11.87 |
| Q1 2020 | -1,404 | Reduce 7.73% | 16,751 | $10.21 |
| Q4 2019 | +438 | Add 2.47% | 18,155 | $9.86 |
| Q3 2019 | -570 | Reduce 3.12% | 17,717 | $9.37 |
| Q2 2019 | +3,425 | Add 23.05% | 18,287 | $10.23 |
| Q1 2019 | +3,733 | Add 33.54% | 14,862 | $16.82 |
| Q4 2018 | +1,617 | Add 17.00% | 11,129 | $8.54 |
| Q3 2018 | +4,175 | Add 78.23% | 9,512 | $11.67 |
| Q2 2018 | +4,008 | Add 301.58% | 5,337 | $14.05 |
| Q1 2018 | +1,329 | New Buy | 1,329 | $9.78 |
Renaissance Technologies (RenTech)'s Daré Bioscience Investment FAQs
Renaissance Technologies (RenTech) first purchased Daré Bioscience, Inc. (DARE) in Q1 2018, acquiring 1,329 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Daré Bioscience, Inc. (DARE) for 32 quarters since Q1 2018.
Renaissance Technologies (RenTech)'s largest addition to Daré Bioscience, Inc. (DARE) was in Q2 2020, adding 54,340 shares worth $645,000.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 19,295 shares of Daré Bioscience, Inc. (DARE), valued at approximately $37,239.
As of the Q4 2025 filing, Daré Bioscience, Inc. (DARE) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Daré Bioscience, Inc. (DARE) was 72,701 shares, as reported at the end of Q1 2021.